Vytorin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
Conditions:   Dyslipidemias;   High Cholesterol;   Hypercholesterolemia Interventions:   Drug: Obicetrapib;   Drug: Ezetimibe 10mg;   Other: Obicetrapib placebo;   Other: Ezetimibe placebo Sponsor:   NewAmsterdam Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials